Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 4;15(1):241.
doi: 10.1186/s13071-022-05354-z.

Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany

Affiliations

Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany

Annabell Coors et al. Parasit Vectors. .

Abstract

Background: Lyme borreliosis is the most prevalent vector-borne disease in Europe, and numbers might increase due to climate change. However, borreliosis is not notifiable in North Rhine-Westphalia (NRW), Germany. Hence, little is known about the current human seroprevalence in NRW. However, the proportion of Borrelia burgdorferi sensu lato-infected ticks has increased in a NRW nature reserve. The literature suggests increasing age and male sex as risk factors for seropositivity, whereas the influence of socioeconomic status is controversial. Thus, we aimed to determine regional seropositivity for Borrelia burgdorferi sensu lato (B. burgdorferi s.l.) and its risk factors in the Rhineland Study population in Bonn, NRW, and to compare it with previous surveys to evaluate potential effects of climate change.

Methods: We assessed seropositivity in 2865 Rhineland Study participants by determining immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies for B. burgdorferi s.l. using a two-step algorithm combining enzyme-linked immunosorbent assay tests and line immunoblots. We calculated the odds of being classified as IgG or IgM positive as a function of age, sex, and educational level using binomial logistic regression models. We applied varying seropositivity classifications and weights considering age, sex and education to compensate for differences between the sample and regional population characteristics.

Results: IgG antibodies for B. burgdorferi s.l. were present in 2.4% and IgM antibodies in 0.6% of the participants (weighted: 2.2% [IgG], 0.6% [IgM]). The likelihood of IgG seropositivity increased by 3.0% (95% confidence interval [CI] 1.5-5.2%) per 1 year increase in age. Men had 1.65 times the odds for IgG seropositivity as women (95% CI 1.01-2.73), and highly educated participants had 1.83 times the odds (95% CI 1.10-3.14) as participants with an intermediate level of education. We found no statistically significant link between age, sex, or education and IgM seropositivity. Our weighted and age-standardized IgG seroprevalence was comparable to the preceding serosurvey German Health Interview and Examination Survey for Adults (DEGS) for NRW.

Conclusions: We confirmed that increasing age and male sex are associated with increased odds for IgG seropositivity and provide evidence for increased seropositivity in the highly educated group. B. burgdorferi s.l. seropositivity remained constant over the past decade in this regional German population.

Keywords: Antibodies; Enzyme-linked immunosorbent assay; Germany; Immunoblotting; Immunoglobulin G; Immunoglobulin M; Lyme disease; Seroepidemiological studies; Tick-borne diseases; Ticks.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Results for ELISA and line immunoblot. A Flowchart for IgG antibodies; B Flowchart for IgM antibodies

Similar articles

Cited by

References

    1. Robert Koch Institut. RKI-Ratgeber Lyme-Borreliose. Epidemiol Bull. 2019;17.
    1. Enkelmann J, Böhmer M, Fingerle V, Siffczyk C, Werber D, Littmann M, et al. Incidence of notified Lyme borreliosis in Germany, 2013–2017. Sci Rep. 2018;8:2013–2017. doi: 10.1038/s41598-018-33136-0. - DOI - PMC - PubMed
    1. Akmatov MK, Holstiege J, Dammertz L, Kohring C, Heuer J, Bätzing J. Nationwide and small-area morbidity of Lyme borreliosis in Germany based on ambulatory claims data, 2010 – 2019. In: Central Research Institute of Ambulatory Health Care in Germany (Zi). Versorgungsatlas-Report Nr. 21/06, Berlin. 2021. 10.20364/VA-21.06
    1. Böhmer MM, Ens K, Böhm S, Heinzinger S, Fingerle V. Epidemiological surveillance of Lyme borreliosis in Bavaria, Germany, 2013–2020. Microorganisms. 2021;9:2013–2020. doi: 10.3390/microorganisms9091872. - DOI - PMC - PubMed
    1. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461–473. doi: 10.1016/S0140-6736(11)60103-7. - DOI - PubMed

LinkOut - more resources